Q&A by Doctor Jeremie Calais on how PSMA PET imaging will change the landscape of prostate cancer detection and treatment. The new imaging technique can locate cancer lesions not only in the prostate, but can also track cancer that has spread to other parts of the body that is often missed by current standard-of-care imaging techniques.
"Access to PSMA PET will be widely available and this game-changer technology will ultimately become part of the routine staging of prostate cancer patients. Like doing a PSA test, I anticipate in a near future that physicians will routinely require a PSMA PET scan before making a treatment plan." Dr. Jeremie Calais.Other news & events
- News12.05.2026

#ASCO26 - Radiopharmaceutical Therapy in Oncology: Practical Integration for Practicing Oncologists
Read more - News11.05.2026

Oncidium foundation partners with Curium to expand access to Radioligand Therapy worldwide
Read more - News22.04.2026

Addressing Barriers to Radioligand Therapy at the European Parliament
Read more




